Trexquant Investment’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Sell |
58,674
-48,618
| -45% | -$10.1M | 0.07% | 378 |
|
|
2026
Q1 | $24.1M | Buy |
107,292
+69,438
| +183% | +$17.3M | 0.17% | 120 |
|
|
2025
Q4 | $9.12M | Buy |
+37,854
| New | +$9.68M | 0.08% | 346 |
|
|
2025
Q3 | – | Sell |
-8,250
| Closed | -$2.13M | – | 1862 |
|
|
2025
Q2 | $2.13M | Buy |
+8,250
| New | +$1.97M | 0.02% | 865 |
|
|
2024
Q4 | – | Sell |
-105,820
| Closed | -$25.8M | – | 1807 |
|
|
2024
Q3 | $25.8M | Buy |
105,820
+64,326
| +155% | +$14.4M | 0.33% | 46 |
|
|
2024
Q2 | $7.94M | Buy |
+41,494
| New | +$8.42M | 0.12% | 255 |
|
|
2024
Q1 | – | Sell |
-24,103
| Closed | -$4.15M | – | 1730 |
|
|
2023
Q4 | $4.15M | Sell |
24,103
-41,024
| -63% | -$6.3M | 0.09% | 307 |
|
|
2023
Q3 | $9.63M | Buy |
65,127
+20,608
| +46% | +$3.73M | 0.24% | 88 |
|
|
2023
Q2 | $9.73M | Buy |
+44,519
| New | +$9.92M | 0.26% | 88 |
|
|
2022
Q1 | – | Sell |
-14,602
| Closed | -$3.8M | – | 1660 |
|
|
2021
Q4 | $3.8M | Buy |
14,602
+5,252
| +56% | +$1.36M | 0.24% | 98 |
|
|
2021
Q3 | $2.46M | Buy |
+9,350
| New | +$2.56M | 0.2% | 145 |
|
|
2020
Q4 | – | Sell |
-20,239
| Closed | -$3.47M | – | 1416 |
|
|
2020
Q3 | $3.47M | Buy |
+20,239
| New | +$3.74M | 0.22% | 117 |
|
|
2020
Q2 | – | Sell |
-3,820
| Closed | -$563K | – | 1423 |
|
|
2020
Q1 | $563K | Buy |
+3,820
| New | +$608K | 0.04% | 618 |
|
|
2019
Q4 | – | Sell |
-15,388
| Closed | -$2.08M | – | 1235 |
|
|
2019
Q3 | $2.08M | Buy |
+15,388
| New | +$2.02M | 0.18% | 162 |
|
|
2018
Q4 | – | Sell |
-17,457
| Closed | -$2.01M | – | 1269 |
|
|
2018
Q3 | $2.01M | Buy |
+17,457
| New | +$1.91M | 0.15% | 204 |
|
|
2018
Q2 | – | Sell |
-3,753
| Closed | -$370K | – | 1157 |
|
|
2018
Q1 | $370K | Buy |
+3,753
| New | +$355K | 0.03% | 734 |
|
|
2017
Q1 | – | Sell |
-13,544
| Closed | -$840K | – | 1288 |
|
|
2016
Q4 | $840K | Sell |
13,544
-6,756
| -33% | -$414K | 0.13% | 231 |
|
|
2016
Q3 | $1.31M | Buy |
+20,300
| New | +$1.35M | 0.29% | 86 |
|
|
2015
Q4 | – | Sell |
-10,454
| Closed | -$532K | – | 1228 |
|
|
2015
Q3 | $532K | Buy |
+10,454
| New | +$563K | 0.05% | 703 |
|
Other funds holding RMD
Trexquant Investment's RMD Position: Q2 2026 in Review
Trexquant Investment reduced its ResMed (RMD) stake by 45% in Q2 2026, selling an estimated $10.1M and leaving 58,674 shares worth $11.4M. The position accounts for 0.07% of the portfolio, ranked #378.
Trexquant Investment first reported a position in RMD in Q3 2015 and has held it in 19 quarters since. The position peaked at $25.8M in Q3 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Trexquant Investment held 58,674 shares of ResMed worth $11.4M as of Q2 2026.
- Trexquant Investment sold 48,618 ResMed shares in Q2 2026, an estimated $10.1M.
- ResMed made up 0.07% of Trexquant Investment's portfolio in Q2 2026, its #378 holding.
- Trexquant Investment first reported a position in ResMed in Q3 2015 and has held it in 19 quarters since.
- Trexquant Investment's ResMed position peaked at $25.8M in Q3 2024.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.